End to End Tokenization of Clinical Trials/Observational Studies & Subsequent Analysis of Real-World Data
Time: 12:00 pm
day: Pre-Conference Day
Details:
Tokenization plays a crucial role in real-world data (RWD) by providing robust security and privacy protection for sensitive patient information. By replacing personally identifiable information (PII) with unique tokens, tokenization ensures that patient data remains confidential while still enabling comprehensive data analysis and linkage across various datasets, such as electronic health records (EHRs) and claims data. This process facilitates longitudinal studies and multi-source data integration without compromising patient privacy, thereby enhancing the reliability and depth of insights derived from RWD. Moreover, tokenization helps meet stringent regulatory requirements and ethical standards, ensuring that research can advance safely and responsibly.
- Importance of tokenizing clinical trial subjects and linking to RWD
- Understanding the end-to-end tokenization process for clinical trials/prospective observational studies
- Situation based insights in handling bias in RWD post linking trial subjects to RWD?
